|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.242 DKK | +1.68% |
|
+0.83% | -43.72% |
| 05-17 | Pharma Equity Group A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 05-16 | Pharma Equity Group A/S Maintains Group Earnings Guidance for the Full Year of 2024 | CI |
Pharma Equity Group A/S reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net income was DKK 3.48 million compared to DKK 5.39 million a year ago. Basic earnings per share from continuing operations was DKK 0.19 compared to DKK 0.19 a year ago.
Diluted earnings per share from continuing operations was DKK 0.16 compared to DKK 0.19 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -43.72% | 35.61M | |
| +23.76% | 84.26B | |
| +10.03% | 17.63B | |
| +57.40% | 17.21B | |
| +10.43% | 14.94B | |
| -3.59% | 12.52B | |
| +12.48% | 11.68B | |
| -0.18% | 11.01B | |
| +28.43% | 10.08B | |
| +73.38% | 8.86B |
PHARMA EQUITY GROUP A/S 
